Pancreatic Cancer Research

ResearcherChinese PLA General HospitalNo recent work listed

Zizheng Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5983-5326; OpenAlex author ID A5059460381. Sources: OpenAlex.

Their work

Papers
5
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: 2 papers · 2022: none · 2023: 1 paper

Papers 5

  1. 18F-FDG-PET/CT-based deep learning model for fully automated prediction of pathological grading for pancreatic ductal adenocarcinoma before surgery. Co-author DOI 10.1186/s13550-023-00985-4↗
  2. Up-regulation of S100P predicts the poor long-term survival and construction of prognostic signature for survival and immunotherapy in patients with pancreatic… Co-author DOI 10.1080/21655979.2021.1992331↗
  3. Identification of the immune cell infiltration landscape in pancreatic cancer to assist immunotherapy. Co-author DOI 10.2217/fon-2021-0495↗
  4. GDF11 restrains tumor growth by promoting apoptosis in pancreatic cancer. Co-author DOI 10.2147/ott.s181792↗
  5. Expression and Prognostic Value of Indoleamine 2,3-dioxygenase in Pancreatic Cancer. Co-author DOI 10.4103/0366-6999.201613↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rong Liu · 3 shared papers, 2021–2023 · strength 0.47
  2. Minggen Hu · 3 shared papers, 2018–2021 · strength 0.39
  3. Fei Wang · 2 shared papers, 2021–2023 · strength 0.33
  4. Gong Zhang · 2 shared papers, 2021–2023 · strength 0.33
  5. Wenbo Zou · 2 shared papers, 2021 · strength 0.30
  6. Yanzhe Liu · 2 shared papers, 2018–2023 · strength 0.27
  7. Yue Zhang · 1 shared paper, 2023 · strength 0.18
  8. Lincheng Li · 1 shared paper, 2021 · strength 0.15
  9. Wei Jing · 1 shared paper, 2018 · strength 0.09
  10. Tao Zhang · 1 shared paper, 2017 · strength 0.08
  11. Rong Liu · 1 shared paper, 2017 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.